Skip to content
Government-backed FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 19 SOURCES

Bayern Kapital

Wholly owned venture capital subsidiary of the Bavarian state development bank LfA Förderbank Bayern

Also known as Bayern Kapital GmbH

Landshut-based venture capital subsidiary of LfA Förderbank Bayern; about €1.3bn under management, €250k–€50M tickets in Bavarian tech startups and scaleups.

Not to be confused with BayBG Bayerische Beteiligungsgesellschaft (Munich), the separate Bavarian MBG that often co-invests as a private mirror partner.

HEADQUARTERS
Landshut, Germany
FOUNDED
1995
OUTSIDE CAPITAL
—
TEAM LISTED
38 people

Focus

STAGES
Pre-SeedSeedSeries ASeries BGrowth
ASSET MIX
Venture capitalDirect investments
GEOGRAPHY
Germany

Investment arms & vehicles

Overview

Bayern Kapital GmbH has been the venture capital investor of the Free State of Bavaria since 1995 and is a wholly owned subsidiary of LfA Förderbank Bayern, based in Landshut. It manages about €1.3bn across several funds, from the Seedfonds Bayern to the €500M Wachstums- und ScaleUp-Fonds, and says it has financed more than 380 Bavarian high-tech startups, with about 120 active portfolio companies. It always invests as a co-investor alongside private investors on pari-passu terms, as a minority shareholder, with holding periods of usually five to ten years.

Investment thesis

Bavarian high-tech and deep-tech startups and scaleups with scalable product businesses (biotech and life sciences, medtech, software and IT, environmental and nanotechnology, materials), from pre-seed to growth and exit, always alongside private co-investors.

PORTFOLIO (161)

  • 36ZEROVision
  • 4screen
  • abaut GmbH
  • adnymics GmbH
    Exited
  • ADVANOVA GmbH
  • Akhetonics
  • AlfaDocs
  • All3DP
  • Altruja
    Exited
  • Amplifold
  • AMW
    Exited
  • apaleo
  • AppNavi
  • Aves
  • Bilendo GmbH
  • Böhner-EH GmbH
    Exited
  • BOX ID Systems
  • Caire
  • casavi
  • CatalYm
  • Cevotec GmbH
    Exited
  • ChargeX
  • ChromoTek
    Exited
  • Cliniserve
  • Cobrainer
  • commercetools
    Exited
  • Conntac
  • Constellr
  • COREDINATE
    Exited
  • Corimmun
    Exited
  • CPTx
  • Crealytics
  • Cunesoft GmbH
    Exited
  • DeepDrive
  • deepeye Medical
  • Delicious Data
  • DRIMCO GmbH
  • driveblocks
  • Dynamic Biosensors
    Exited
  • Easy-Tutor
  • Ebenbuild
  • EcoG
  • EGYM
  • eKidz.eu
  • emax digital
  • encosa
  • Enmacc
  • EOS
    Exited
  • Erium
  • Ewigbyte
  • ExB Labs
  • Exergy3
  • ExoMatter
  • EXTEND3D
    Exited
  • EyeSense GmbH
    Exited
  • famPLUS
  • Fazua
    Exited
  • Filics
  • Flowsight
  • fos4X
    Exited
  • FTAPI
    Exited
  • Gastfreund
  • GeneArt AG
    Exited
  • GME German Medical Engineering
    Exited
  • GNA Biosolutions
    Exited
  • hema.to
  • HiveMQ
  • Hololight
  • iATROS
    Exited
  • Immunic Therapeutics
  • inContAlert
  • Insempra
  • IQM Quantum Computers
  • Isar Aerospace
  • knowis AG
  • leadtributor
  • Limata
  • LUMA Vision
  • Maple Aviation GmbH
  • Marvel Fusion
  • mbiomics
  • MC Sciences
  • Medineering GmbH
    Exited
  • memtime
  • Metoda
    Exited
  • Micromet
    Exited
  • Morphosys
    Exited
  • multimmune
  • Multiphoton Optics
    Exited
  • munevo
  • Munich Quantum Instruments
  • Nanda Technologies
    Exited
  • NanoStruct
  • Nature Robots
  • NeoPredics AG
  • Neuramancer AI
  • Noxon
  • NUCLIDIUM AG
  • Numares HEALTH
  • OCELL
  • oculai
  • ondeso
    Exited
  • OroraTech
  • parcelLab
    Exited
  • PartSpace
  • Pelicad
  • Photonics Healthcare
    Exited
  • Picture Framing GmbH (Mozaik)
  • Planet A Foods
  • Planqc
  • Plixos
    Exited
  • ProGlove
    Exited
  • Propertybase
    Exited
  • Proxima Fusion
  • Pulsetrain
  • Qbilon
    Exited
  • Quantum Systems
  • QuantumDiamonds GmbH
  • Reflex Aerospace
  • reINVENT
    Exited
  • riskmethods
    Exited
  • Ryte
    Exited
  • SciRhom
  • Scompler Technologies
  • Secfix
  • sewts
  • SimScale
  • SIRION Biotech
    Exited
  • Smart Reporting
  • SmartAIs
  • smartbax
  • SPiNE
  • StrategyBridgeAI
  • Sunhill technologies GmbH
    Exited
  • SuppreMol GmbH
    Exited
  • Symphera
  • T-Curx
  • tado°
  • The Electric Car Scheme
  • The Exploration Company
  • Thermosome GmbH
  • THEVA Dünnschichttechnik GmbH
    Exited
  • Tidely GmbH
  • tiramizoo
    Exited
  • TM3
    Exited
  • TNI Medical
    Exited
  • traplinked GmbH
  • TRiCares
  • Tubulis
    Exited
  • Twogee Biotech
  • ubiMaster
  • Vanatec
    Exited
  • Vantis
  • VEACT
    Exited
  • Vectoflow
  • virtonomy.io
  • VITAS
  • workerbase
  • WorkerHero
  • XO Life
  • Subra
    Climate & Energy · since 2026

People

  • Monika Steger
    Managing Director · source
  • Markus Mrachacz
    Managing Director · source
  • Dr. Sabine Jarothe
    Chair of the Supervisory Board · source
  • Bernd Schafberger
    Head of Venture Capital Investments, Prokurist · source
  • Bernhard Köhler
    Investment Director and Prokurist · source
  • Ariel Golan
    Investment Director · source
  • Benjamin Schwiewagner
    Investment Director · source
  • Dr. Nathalie Weitemeyer
    Director Life Science and Senior Investment Manager · source
  • Klaus Löschner
    Team Lead and Prokurist · source
  • Madeleine Guggenheim
    Head of Marketing, Communications & Relations · source
  • Martin Redl
    Investment Director · source
  • Simon Kreitmair
    Investment Director · source
  • Stefan Engl
    Head of Finance and Administration, Prokurist · source
  • Thomas Hutter
    Chief Risk Officer and Prokurist · source
  • Wolfgang Dengler
    Head of Venture Capital Investments, Prokurist · source
  • Wolfgang Härtl
    Investment Director · source
  • Andreas Huber
    Senior Investment Manager · source
  • Brigitte Linseis
    Senior Investment Manager · source
  • Ahmet Bayram
    Investment Manager · source
  • Bettina Grotz
    Investment Manager · source
  • Christoph Wirth
    Senior Investment Manager · source
  • Franz Salzer
    Senior Investment Manager · source
  • Franz Wocheslander
    Senior Investment Manager · source
  • Dominik Neumüller
    Investor Relations Manager · source
  • Florian Ebel
    Investment Manager · source
  • Florian Zeidler
    Investment Manager · source
  • Lisa Liu
    Senior Investment Manager · source
  • Franziska Pfeiffer
    Investment Manager · source
  • Katerina Straub
    Head of Controlling · source
  • Markus Porsch
    Investment Manager · source
  • Mathias Matusek
    Investment Manager · source
  • Matthias Buchinger
    Investment Manager · source
  • Matthias Wolf
    Investment Manager · source
  • Regina Graßl
    Senior Investment Manager · source
  • Thomas Manitta
    Senior Investment Manager · source
  • Sarah Gscheider
    Investment Manager · source
  • Stefan Aumer
    Investment Manager · source
  • Dr. Vanessa Luzak
    Investment Manager · source

Links

Frequently asked questions

Bayern Kapital is a government-backed fund based in Landshut, Germany, founded in 1995.

Yes. Bayern Kapital invests its own capital in private companies.

Bayern Kapital invests at Pre-Seed, Seed, Series A, Series B and Growth stages in Deep Tech, Software & SaaS, Biotech & Life Sciences, HealthTech, Climate & Energy, Industrial & Manufacturing, Space and Artificial Intelligence.

Bayern Kapital's stated ticket size is €250K–€50M.

Key people at Bayern Kapital include Monika Steger (Managing Director), Markus Mrachacz (Managing Director), Dr. Sabine Jarothe (Chair of the Supervisory Board) and Bernd Schafberger (Head of Venture Capital Investments, Prokurist).

Bayern Kapital's investments include 36ZEROVision, 4screen, abaut GmbH, adnymics GmbH, ADVANOVA GmbH, Akhetonics, AlfaDocs and All3DP, among others.

The most recent publicly reported investment by Bayern Kapital is Subra, announced in Jul 2026.

Bayern Kapital states that it accepts submissions through its official contact page.